Home LiteratureArticle Details
PMID: 1736895 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Polymorphism and proteolytic fragments of granulocyte membrane cofactor protein (MCP, CD46) of complement.

The Biochemical journal ·Vol. 281 ( Pt 2) ·1992-01-15 ·Pages 493-9

Matsumoto M, Seya T, Nagasawa S

Abstract

Human granulocytes (polymorphonuclear leucocytes, PMN) possess a membrane cofactor protein (MCP, CD46), which is structurally and functionally distinct from the MCPs of other cell types: it shows a single broad band of 56-80 kDa (without the doublet pattern characteristic of MCP) on SDS/PAGE and has less affinity for complement component C3b. We purified PMN MCP using monoclonal antibodies in order to study the molecular differences between it and other MCPs. Several forms of PMN MCP with size heterogeneity were noted on SDS/PAGE and by immunoblotting. O-Glycanase treatment decreased this heterogeneity, yielding a fast-migrating component identical in position on SDS/PAGE to the O-glycanase-treated MCP of other cells. The cell-specific variation of MCP, therefore, arises from post-translational glycosylation and not from a difference in primary structure. The Factor I cofactor activity of PMN MCP was more efficient in cleaving the methylamine-treated complement components C4/C3 than was MCP from other cells, which shared a similar potency of cofactor activity on a weight basis. Two types of small-form PMN MCP were identified during purification. These were 42 kDa and 30 kDa in size; the former was recognized by M177 (a monoclonal antibody against the active site marker), possessed N-linked sugars [located on the short consensus repeats (SCRs)] but not O-linked ones (on the Ser/Thr-rich region), and retained cofactor activity for C3b/C4b cleavage, similar in potency to that of other MCPs. The functionally active soluble form of MCP was observed specifically in PMN. Protease inhibitors did not inhibit liberation of the fragments, although the generated fragments became susceptible to serine proteases. The findings show that the SCRs are the functional domain of MCP and that the MCP proteolysis found only in PMN may modulate the properties of PMN MCP. In conclusion, the structural features of PMN MCP largely reflect a variability in the O-linked sugars, and the decreased affinity for C3b may be in part attributable to proteolysis.

MeSH Terms
Antigens, CD Blotting, Western Cathepsin G Cathepsins/pharmacology Cell Line Complement System Proteins/chemistry,metabolism Electrophoresis, Polyacrylamide Gel Glycoside Hydrolases/metabolism Granulocytes/chemistry Humans Leukocytes, Mononuclear/chemistry Membrane Cofactor Protein Membrane Glycoproteins/chemistry,metabolism Neutrophils/chemistry Pancreatic Elastase/metabolism Peptide Fragments/chemistry,metabolism Polymorphism, Genetic Serine Endopeptidases
Chemicals
Antigens, CD CD46 protein, human Membrane Cofactor Protein Membrane Glycoproteins Peptide Fragments Complement System Proteins Glycoside Hydrolases Cathepsins Serine Endopeptidases CTSG protein, human Cathepsin G Pancreatic Elastase
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Matsumoto M
Department of Immunology, Center for Adult Diseases Osaka, Japan.
Seya T
Nagasawa S
References (36)
36 references, click to expand
  1. Alternative complement pathway-mediated myeloid cell cytotoxicity: repertoire of membrane factors participating in regulation of C3 deposition and cytolysis.
    Eur J Immunol. 1991 Aug;21(8):1787-92 PMID: 1714391
  2. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.
    Proc Natl Acad Sci U S A. 1979 Nov;76(11):5867-71 PMID: 293688
  3. Complement-mediated tumor cell damage induced by antibodies against membrane cofactor protein (MCP, CD46).
    J Exp Med. 1990 Dec 1;172(6):1673-80 PMID: 2258699
  4. Additional forms of human decay-accelerating factor (DAF).
    J Immunol. 1987 Aug 15;139(4):1260-7 PMID: 2440950
  5. Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipid.
    Biochemistry. 1986 Nov 4;25(22):6740-7 PMID: 2432921
  6. The PI-linked receptor FcRIII is released on stimulation of neutrophils.
    Nature. 1988 Jun 16;333(6174):667-9 PMID: 2967437
  7. Loss of complement receptor type 1 (CR1) on ageing of erythrocytes. Studies of proteolytic release of the receptor.
    Biochem J. 1986 May 1;235(3):815-21 PMID: 2944510
  8. Biochemical characterization of membrane cofactor protein of the complement system.
    J Immunol. 1988 Dec 1;141(11):3923-9 PMID: 3053903
  9. Distribution of membrane cofactor protein of complement on human peripheral blood cells. An altered form is found on granulocytes.
    Eur J Immunol. 1988 Aug;18(8):1289-94 PMID: 3046951
  10. Functional properties of membrane cofactor protein of complement.
    Biochem J. 1989 Dec 1;264(2):581-8 PMID: 2481448
  11. Membrane cofactor protein of complement is present on human fibroblast, epithelial, and endothelial cells.
    J Clin Invest. 1989 Aug;84(2):538-45 PMID: 2474570
  12. Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement.
    Proc Natl Acad Sci U S A. 1987 Apr;84(7):2007-11 PMID: 2436222
  13. Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins.
    Nature. 1987 Feb 5-11;325(6104):545-9 PMID: 2433596
  14. Characterization of the human trophoblast-leukocyte antigenic molecules defined by a monoclonal antibody.
    J Immunol. 1986 Sep 1;137(5):1604-9 PMID: 2427575
  15. Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors.
    Science. 1989 Sep 15;245(4923):1238-41 PMID: 2551036
  16. Probing the C4-binding site on C1s with monoclonal antibodies. Evidence for a C4/C4b-binding site on the gamma-domain.
    J Immunol. 1989 Apr 15;142(8):2743-50 PMID: 2522968
  17. Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP). Evidence for inclusion in the multigene family of complement-regulatory proteins.
    J Exp Med. 1988 Jul 1;168(1):181-94 PMID: 3260937
  18. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.
    J Exp Med. 1984 Nov 1;160(5):1558-78 PMID: 6238120
  19. A polymorphism of the complement regulatory protein MCP (membrane cofactor protein or gp45-70).
    J Immunol. 1987 Jun 1;138(11):3850-5 PMID: 3584971
  20. Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b.
    J Exp Med. 1986 Apr 1;163(4):837-55 PMID: 3950547
  21. Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines.
    Proc Natl Acad Sci U S A. 1985 Feb;82(3):859-63 PMID: 3871945
  22. Limited proteolysis of a chemically modified third component of human complement, C3, by cathepsin G of human leukocytes.
    J Biochem. 1985 Jul;98(1):229-36 PMID: 4044552
  23. Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation.
    J Immunol. 1990 Jul 1;145(1):238-45 PMID: 1694203
  24. Shedding of tumor necrosis factor receptors by activated human neutrophils.
    J Exp Med. 1990 Aug 1;172(2):599-607 PMID: 2165128
  25. The human cell-surface glycoproteins HuLy-m5, membrane co-factor protein (MCP) of the complement system, and trophoblast leucocyte-common (TLX) antigen, are CD46.
    Immunology. 1990 Jun;70(2):155-61 PMID: 2373515
  26. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.
    J Immunol. 1982 Jul;129(1):184-9 PMID: 6211481
  27. Modulation of the alternative complement pathways by beta 1 H globulin.
    J Exp Med. 1976 Nov 2;144(5):1147-63 PMID: 62817
  28. Mechanism of action of the C3b inactivator: requirement for a high molecular weight cofactor (C3b-C4bINA cofactor) and production of a new C3b derivative (C3b').
    Immunochemistry. 1977 Nov-Dec;14(11-12):749-56 PMID: 146022
  29. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
    Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4 PMID: 388439
  30. Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator.
    J Exp Med. 1978 Oct 1;148(4):1044-51 PMID: 702059
  31. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  32. Complement receptor is an inhibitor of the complement cascade.
    J Exp Med. 1981 May 1;153(5):1138-50 PMID: 6910481
  33. A fluorometric method for determination of C3b inactivator.
    Clin Chim Acta. 1982 Mar 12;119(3):189-96 PMID: 7067118
  34. Purification and characterization of a macromolecular weight cofactor for C3b-inactivator, C4bC3bINA-cofactor, of human plasma.
    Mol Immunol. 1980 Nov;17(11):1365-72 PMID: 7464836
  35. Cleavage of C4b by C3b inactivator: production of a nicked form of C4b, C4b', as an intermediate cleavage product of C4b by C3b inactivator.
    J Immunol. 1980 Aug;125(2):578-82 PMID: 7391570
  36. Expression and characterization of membrane co-factor protein (MCP) in human skin.
    J Invest Dermatol. 1991 Oct;97(4):722-4 PMID: 1940444
Article Info
Journal
The Biochemical journal
Abbr.
Biochem J
ISSN
0264-6021
Published
1992-01-15
Pages
493-9
Language
English
Region
England
NLM ID
2984726R
PMCID
PMC1130712
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]